Evidence map›Paper›PMID 19424797›Full record

ArticleDigestive diseases and sciences2010

A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.

Tolga Yakar, Mustafa Güçlü, Ender Serin, Hikmet Alişkan, Erdamar Husamettin

Erratum issuedAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. JMM case reports · 2016
    Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Spontaneous ascitic fluid infection in liver cirrhosis: bacteriological profile and response to antibiotic therapy.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2013
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

  • Erratum issued
    Husamettin, Erdamar [added]
5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Tolga YakarDepartment of Gastroenterology, Faculty of Medicine, Maremar Medical Center, Baskent University, Ankara, Kahramanmaras, Turkey.
Mustafa Güçlü
Ender Serin
Hikmet Alişkan
Erdamar Husamettin
Başkent University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this research is to evaluate the recent changes in microorganisms causing spontaneous bacterial peritonitis in cirrhotic patients, antibiotic resistance, and response to empirical cephalosporin therapy. A total of 218 patients with ascites secondary to cirrhosis were enrolled. Parenteral cefotaxime or cefepime was given to patients who had a neutrophil count of 250/mm(3) or more or a positive bacterial culture of ascitic fluid. Antibiotic failure was defined by an absence of clinical improvement and an insufficient decrease in neutrophil count of ascites (<25% of initial value) by the third day of therapy. Of all the patients, 44.6% had culture-negative neutrocytic ascites, 24.8% had spontaneous bacterial peritonitis, and 10.1% had monomicrobial nonneutrocytic bacterascites. Growth in culture was observed in 76 patients (34.9%). The two most common isolated bacteria were Escherichia coli (33.8%) and coagulase-negative Staphylococcus (CoNS; 19.7%). The two cephalosporins were effective against E. coli (82%) and but not against CoNS (44%), while levofloxacin showed reasonable activity against both E. coli (71%) and CoNS (90%) in vitro. We confirmed a recent increased incidence of spontaneous bacterial peritonitis caused by Gram-positive bacteria. Levofloxacin seems to be a good alternative treatment for patients with uncomplicated spontaneous ascites infections.

Indexed as

Drug Resistance, BacterialAdultAgedAged, 80 and overAnti-Bacterial AgentsAscitic FluidBacterial InfectionsCefepimeCefotaximeCephalosporinsEnterococcusEscherichia coli InfectionsFemaleHumansInfusions, IntravenousKlebsiella InfectionsAnti-Bacterial AgentsCefepimeCefotaximeCephalosporinsLevofloxacinOfloxacin

Identifiers

PMID19424797
OpenAlexW1965500250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.